JPMorgan Chase & Co. Increases Colgate-Palmolive (NYSE:CL) Price Target to $99.00

Colgate-Palmolive (NYSE:CL) had its price objective raised by JPMorgan Chase & Co. from $97.00 to $99.00 in a report released on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

A number of other research firms also recently weighed in on CL. Stifel Nicolaus decreased their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Barclays decreased their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Raymond James reissued an “outperform” rating and issued a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Finally, UBS Group decreased their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $101.72.

Colgate-Palmolive Stock Down 0.8 %

Colgate-Palmolive stock opened at $89.80 on Friday. The company has a market cap of $72.87 billion, a P/E ratio of 25.51, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a fifty day simple moving average of $89.02 and a 200 day simple moving average of $94.82. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the company earned $0.87 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $26,000. Centricity Wealth Management LLC acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $27,000. Vermillion Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $31,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. Finally, Briaud Financial Planning Inc acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.